pISSN 2234-3806eISSN 2234-3814
Patient characteristics and concurrent NGS results
| No. Case | Diagnosis | Sex | Age at diagnosis (yrs) | Fusion gene 1 (exon breakpoint) | Fusion gene 2 (exon breakpoint) | Immunophenotype | Karyotype | Tier 1/2 variants from targeted NGS (VAF, %) |
Total follow-up period/relapse/death (months) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | T-ALL | F | 26 | SET (7) | NUP214 (18) | CD34, CD3, HLA-DR, CD7, CD13, CD33, CD79a | Uninterpretable result | WT1 c.1372C>T (40.0), TP53 c.560-27_560delinsTAGA (23.7), TP53 c.844C>T (42.7), EZH2 c.1707_1708insGCGTTTCG (15.0) | 9/ 6/ 9 |
| 2 | AML | M | 12 | SET (7) | NUP214 (18) | CD117, CD34, CD11c, CD11b, HLA-DR, CD33, CD7 | 46,XY [20] | PHF6 c.902_903delinsTTATTTGTT (18.0), PHF6 exon 9 deletion (NA) | 37/ -/ - |
| 3 | AUL | F | 31 | SET (7) | NUP214 (18) | CD117, CD34, CD38, CD7, CD33 | 46,XX [20] | WT1 c.1384del (43.8), PHF6 c.834+1G>C (40.1), GNB1 c.229G>A (43.4), EED c.676_677insCCAG (41.2) | 19/ -/ - |
| 4 | T-ALL | F | 11 | SET (7) | NUP214 (18) | CD38, CD7, CD33, CD34, CD5, cCD3 | 46,XX,del(1)(p36.2) [18] | NOTCH1 c.6943C>T (47.3), SUZ12 c.814G>T (51.9), DNM2 c.1153C>T (46.7), IL7R c.711_729delinsAAGATGCGTT (43.6), PHF6 c.681_682insGAGAC (45.3) | 4/ -/ - |
| 5 | AML | M | 69 | DEK (9) | NUP214 (18) | CD117, CD34, cMPO, CD38, HLA-DR, CD33, CD13 | 46,XY,t(6;9)(p22;q34) [20] | FLT3-ITD (NA), NRAS c.35G>A (14.8) | 13/ -/ - |
| 6 | AML | F | 76 | DEK (8) | NUP214 (18) | CD117, CD34, cMPO, CD7, CD11c, HLA-DR, CD33, CD13 | 46,XX,t(6;9)(p22;q34)[20] | FLT3-ITD (NA) | 4/ -/ 4 |
| 7 | AML | F | 59 | DEK (9) | NUP214 (18) | Not done |
46,XX,t(6;9)(p22;q34)[16]/46,XX [4] | FLT3-ITD (NA), KDM6A c.3490_3494dup (12.1) | 32/ -/ - |
| 8 | AMKL | M | 3 | NUP214 (34) | ABL1 (2) | CD34, CD7, CD33, CD13, CD117 | 46,XY,der(13;21)(q10;q10)c,der(18)t(1;18)(q12;q22),+21c [24] | BRCA2 c.8912del (49.3) |
74/ 21/ - |
| 9 | T-ALL | M | 9 | NUP214 (32) | ABL1 (2) | CD38, CD7, CD8, CD4, CD5, CD1a, cCD3 | 46,XY [20] | DNM2 c.1609G>A (49.8), CTCF c.1369C>T (49.3), NOTCH1 c.7327_7328insGG (43.4), NOTCH1 c.4775T>C (47.5), PHF6 c.507_508insGT (94.1), CDKN2A whole-gene deletion, CDKN2B whole-gene deletion, EZH2 whole-gene deletion, RB1 whole-gene deletion | 9/ -/ - |
| 10 | T-ALL | F | 12 | NUP214 (32) | ABL1 (2) | CD117, CD34, CD7, CD33, CD4, cCD3 | 46,XX [22] | WT1 c.366dup (11.1), WT1 c.1156_1157insGGCGGACCGGT (63.6), PHF6 c.720T>G (16.9), PHF6 c.720T>G (44.1), FBXW7 c.1513C>T (15.1), NRAS c.34G>C (14.4), NOTCH1 c.4754T>C (14.3), DNM2 c.1948G>T (37.5) | 25/ 22/ - |
| 11 | AML | F | 72 | NUP214 (29) | ABL1 (2) | CD117, CD34, CD7, CD33, CD4, cCD3 | 45–47,XX,-2,-3,der(3)t(3;?)(p21;?),-5,?der(5)t(5;?)(q12;?),-7,der(7)t(7;?)(?p21;?),+8,+?der(16)t(16;?)(q12-13;?),-18,-19,-19,+20,+3–5mar[cp20a/46,XX [1] | TP53 c.524G>A (45.1), TP53 c.613T>G (46.8), IDH2 c.515G>A (24.5), RAD50 c.3883C>T (7.5), DDX41 whole-gene deletion, NPM1 whole-gene deletion, RAD50 whole-gene deletion | 1/ -/ - |
*Reference transcripts were as follows: NM_024426.4 for WT1, NM_000546.5 for TP53, NM_004456.4 for EZH2, NM_001015877.1 for PHF6, NM_001282539.1 for GNB1, NM_003797.3 for EED, NM_017617.5 for NOTCH1, NM_015355.4 for SUZ12, NM_001005360.3 for DNM2, NM_002185.5 for IL7R, NM_002524.5 for NRAS, NM_021140.4 for KDM6A, NM_000059.3 for BRCA2, NM_002049.3 for GATA1, NM_022051.2 for EGLN1, NM_006565.3 for CTCF, NM_033632.3 for FBXW7, NM_002168.4 for IDH2, NM_005732.4 for RAD50.
†Positive expression of CD34 and CD117 in leukemic blasts was confirmed via immunohistochemistry.
‡This was a germline pathogenic mutation.
Abbreviations: NGS, next-generation sequencing; T-ALL, T-cell acute lymphoblastic leukemia; AML, acute myeloid leukemia; AUL, acute undifferentiated leukemia; AMKL, acute megakaryocytic leukemia; VAF, variant allele frequency; ITD, internal tandem duplication; NA, not available.
© Ann Lab Med